ÐÇ¿Õ´«Ã½

Das Basel Biomed Symposium soll die wissenschaftliche Vernetzung, Kooperation und Innovation im Life-Science-Ökosystem Basel fördern. In vier Sessions wird das 1. Basel Biomed Symposium Wertschöpfungsketten der biomedizinischen Forschung von den biologischen Grundlagen bis zur klinischen Anwendung aufzeigen.

Programm – Stand 28. April 2025

---

Friday, May 23, 2025

08.45: Welcome and Intro (all Organisers)

08.50 – 10.10: Session I: From Cell Biology to Cell and Tissue Engineering and Therapy
Chairs: Ivan Martin / Prisca Liberali

Ivan Martin (Uni Basel, DBM**)
Introducing the Department of Biomedicine
    
Sai Reddi (D-BSSE, ETHZ*)
Next-generation protein engineering for immunotherapy

Mirjam Christ-Crain (USB*)
Introducing the University Hospital Basel

Nina Khanna / Heinz Läubli (USB*)
Cell therapies: bridging translation into clinical practice

Stefanie Urlinger (Cimeio)
Hematopoietic stem cell engineering enables universal blood cancer therapy

Prisca Liberali (FMI/D-BSSE*)
Cell Coordination in Intestinal Development and Repair

Botond Roska (IOB*)
Introducing the Institute of Molecular and Clinical Ophthalmology Basel

Botond Roska (IOB*)
Cell type targeted mitochondria therapy

Matthias Lütolf (IHB/Roche*)
Introducing the Institute of Human Biology

---

10.10: Coffee

---

10.35 – 11.55: Session II: Digital Medicine and AI in Medicine
Chairs: Daniel Müller / Kirsten Taylor

Daniel Müller (D-BSSE*)                
AI in Medicine Hub Basel

Michael Moor (D-BSSE*)
Tool-using medical AI agents

Judith Zaugg (Uni Basel, DBM*)
Systems epigenetics and spatial profiling to study disease mechanisms

Georg Holländer (BRCCH*)
Digital Hub of the Basel Centre of Child Health

Jens Eckstein (USB*)
Artificial Intelligence in Medicine: Transforming Diagnostics, Treatment, and Patient Care

Philippe Cattin (Uni Basel, DBE*)
From Bench to Bedside: How the DBE Transforms Basic Science and Engineering into Healthcare Breakthroughs

Philippe Cattin (Uni Basel, DBE*)
Leveraging AI and Diffusion Models for Patient Specific Surgical Plans

Kirsten Taylor (Roche)
Digital biomarkers: Remote monitoring of neurologic signs in clinical drug development of neurodegenerative disorders

Jürg Utzinger (Swiss TPH*)
Making the World a Healthier Place

---

12.00: Break «Grundsteinlegung» New DBM and Lunch / Networking

---

13.30 – 14.50: Session III: From Molecular Pathways to Personalised Medicine and Cancer Therapy
Chairs: Primo Schär / Adrian Britschgi

Markus Lill (Uni Basel, DPS *)
tba

Mohamed Bentires-Alj (Uni Basel, DBM*)
Breast Tumor Heterogeneity and Metastasis – From Mechanisms to Personalised Treatments

Walter Weber (USB*)
Surgical De-escalation to Improve the Quality of Life of Patients with Breast Cancer

Niklaus Labhardt (Uni Basel, DKF*)
tba

Elisabetta Traggiai (Novartis)        
T-Cell Engagers, backtranslation from clinic to drug design

Falko Schlottig (FHNW*)
tba

Abdullah Kahraman (FHNW*)
Cancer-specific transcripts as novel biomarker for precision medicine

Annette Luther (Roche)
tba

Adrian Britschgi (pRED/Roche*)
Harnessing cell extrinsic and intrinsic factors to tackle colorectal cancer

---

14.50: Coffee

---

15.20 – 17.00: Session IV: From Neuroscience to Neurology
Chair: Alex Schier / Michaela Kneissel

Alex Schier (Uni Basel, Biozentrum)
tba

Peter Scheiffele (Uni Basel, Biozentrum)
Tuning neuronal wiring and function through selective mRNA translation

Dirk Schübeler (FMI*)
tba

Silvia Arber (FMI, Biozentrum*)
Circuits for Movement

Andreas Papassotiropoulos/ Dominique De Quervain (Uni Basel DBM, UPK*)
Genome-guided discovery of memory-enhancing drugs

Cristina Granziera (Uni Basel DBE, USB*)
Neurology 4.0 & beyond

Michaela Kneissel (Novartis)
tba

Derya Shimshek (Novartis)
Modulation of neuroinflammation as therapeutic approach in chronic neurodegenerative diseases

Alexandre Datta (UKBB*)
tba

---

17.00: Apéro / Networking

---

Scientific Board des Basel Biomed Symposium

• Prof. Dr. Primo Schär, Vice President for Research, ÐÇ¿Õ´«Ã½
• Prof. Dr. Alex Schier, Head Department Biozentrum, ÐÇ¿Õ´«Ã½
• Prof. Dr. Ivan Martin, Head Department of Biomedicine, ÐÇ¿Õ´«Ã½
• Prof. Dr. Jürg Steiger, Chief Medical Director, University Hospital
• Prof. Dr. Daniel Müller, Department BSSE, ETH Zürich
• Dr. Annette Luther, Hoffmann-La Roche
• Dr. Michaela Kneissel, Global Head Diseases of Aging and Regenerative medicine, Novartis

---

* DBM, Department of Biomedicine; FMI Friedrich Miescher Institute for Biomedical Research; D-BSSE, Department of Biosystems Science and Engineering (ETHZ); USB, University Hospital Basel; IOB, Institute of Molecular and Clinical Ophthalmology Basel; IHB, Institute of Human Biology Basel; BRCCH, Basel Research Center for Child Health; DBE; Department of Biomedical Engineering; Swiss TPH, Swiss Tropical and Public Health Institute; DPS, Department of Pharmaceutical Sciences; DKF, Department Clinical Research; FHNW, Fachhochschule Nordwestschweiz; UPK, Universitäre Psychiatrische Kliniken Basel; UKBB, Universitäts-Kinderspital Beider Basel